CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CCLDO • US14167R3084

25.67 USD
-0.08 (-0.31%)
Last: Feb 9, 2026, 08:00 PM
Fundamental Rating

5

CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. CCLDO has only an average score on both its financial health and profitability. While showing a medium growth rate, CCLDO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CCLDO had positive earnings in the past year.
  • In the past year CCLDO had a positive cash flow from operations.
  • CCLDO had negative earnings in each of the past 5 years.
  • CCLDO had a positive operating cash flow in 4 of the past 5 years.
CCLDO Yearly Net Income VS EBIT VS OCF VS FCFCCLDO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • CCLDO's Return On Assets of 2.63% is amongst the best of the industry. CCLDO outperforms 88.57% of its industry peers.
  • With an excellent Return On Equity value of 4.12%, CCLDO belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • CCLDO's Return On Invested Capital of 13.98% is amongst the best of the industry. CCLDO outperforms 94.29% of its industry peers.
Industry RankSector Rank
ROA 2.63%
ROE 4.12%
ROIC 13.98%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
CCLDO Yearly ROA, ROE, ROICCCLDO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Profit Margin of CCLDO (2.08%) is better than 80.00% of its industry peers.
  • Looking at the Operating Margin, with a value of 10.43%, CCLDO belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CCLDO has grown nicely.
  • With a Gross Margin value of 46.49%, CCLDO is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
  • CCLDO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.43%
PM (TTM) 2.08%
GM 46.49%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
CCLDO Yearly Profit, Operating, Gross MarginsCCLDO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

5

2. Health

2.1 Basic Checks

  • CCLDO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CCLDO has been increased compared to 1 year ago.
  • The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
  • The debt/assets ratio for CCLDO has been reduced compared to a year ago.
CCLDO Yearly Shares OutstandingCCLDO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CCLDO Yearly Total Debt VS Total AssetsCCLDO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • CCLDO has an Altman-Z score of 20.80. This indicates that CCLDO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CCLDO (20.80) is better than 100.00% of its industry peers.
  • CCLDO has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
  • The Debt to FCF ratio of CCLDO (0.38) is better than 74.29% of its industry peers.
  • CCLDO has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • CCLDO has a Debt to Equity ratio of 0.12. This is comparable to the rest of the industry: CCLDO outperforms 45.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.38
Altman-Z 20.8
ROIC/WACC1.47
WACC9.51%
CCLDO Yearly LT Debt VS Equity VS FCFCCLDO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • CCLDO has a Current Ratio of 1.26. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
  • CCLDO has a worse Current ratio (1.26) than 74.29% of its industry peers.
  • CCLDO has a Quick Ratio of 1.15. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
  • CCLDO has a Quick ratio of 1.15. This is in the lower half of the industry: CCLDO underperforms 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.15
CCLDO Yearly Current Assets VS Current LiabilitesCCLDO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

  • CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.27%, which is quite impressive.
  • Looking at the last year, CCLDO shows a small growth in Revenue. The Revenue has grown by 2.97% in the last year.
  • Measured over the past years, CCLDO shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%

3.2 Future

  • CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.73% yearly.
  • The Revenue is expected to grow by 8.34% on average over the next years. This is quite good.
EPS Next Y143.35%
EPS Next 2Y60.03%
EPS Next 3Y43.73%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3Y8.34%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCLDO Yearly Revenue VS EstimatesCCLDO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M
CCLDO Yearly EPS VS EstimatesCCLDO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 641.75, which means the current valuation is very expensive for CCLDO.
  • Based on the Price/Earnings ratio, CCLDO is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 28.06, CCLDO is valued quite expensively.
  • The Price/Forward Earnings ratio is 228.79, which means the current valuation is very expensive for CCLDO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CCLDO is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 27.86. CCLDO is valued rather expensively when compared to this.
Industry RankSector Rank
PE 641.75
Fwd PE 228.79
CCLDO Price Earnings VS Forward Price EarningsCCLDO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CCLDO.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CCLDO.
Industry RankSector Rank
P/FCF 60.13
EV/EBITDA 41.44
CCLDO Per share dataCCLDO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCLDO does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CCLDO may justify a higher PE ratio.
  • CCLDO's earnings are expected to grow with 43.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.48
PEG (5Y)N/A
EPS Next 2Y60.03%
EPS Next 3Y43.73%

5

5. Dividend

5.1 Amount

  • CCLDO has a Yearly Dividend Yield of 9.91%, which is a nice return.
  • CCLDO's Dividend Yield is rather good when compared to the industry average which is at 0.60. CCLDO pays more dividend than 100.00% of the companies in the same industry.
  • CCLDO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 9.91%

5.2 History

  • CCLDO has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of CCLDO decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CCLDO Yearly Dividends per shareCCLDO Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

DPN/A
EPS Next 2Y60.03%
EPS Next 3Y43.73%
CCLDO Yearly Income VS Free CF VS DividendCCLDO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

CARECLOUD INC - CCLD 8 3/4 PERP

NASDAQ:CCLDO (2/9/2026, 8:00:03 PM)

25.67

-0.08 (-0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-27
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner ChangeN/A
Market Cap1.09B
Revenue(TTM)114.31M
Net Income(TTM)2.38M
Analysts80
Price Target55.48 (116.13%)
Short Float %0%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 9.91%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)30.72%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)6.7%
EPS beat(12)8
Avg EPS beat(12)0.7%
EPS beat(16)12
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)2.58%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.44%
Revenue beat(4)2
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.44%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)3
Avg Revenue beat(16)-2.05%
PT rev (1m)22.21%
PT rev (3m)63.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)31.23%
EPS NY rev (1m)-5.56%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 641.75
Fwd PE 228.79
P/S 9.52
P/FCF 60.13
P/OCF 42.64
P/B 18.83
P/tB 177.38
EV/EBITDA 41.44
EPS(TTM)0.04
EY0.16%
EPS(NY)0.11
Fwd EY0.44%
FCF(TTM)0.43
FCFY1.66%
OCF(TTM)0.6
OCFY2.35%
SpS2.7
BVpS1.36
TBVpS0.14
PEG (NY)4.48
PEG (5Y)N/A
Graham Number1.11
Profitability
Industry RankSector Rank
ROA 2.63%
ROE 4.12%
ROCE 17.7%
ROIC 13.98%
ROICexc 14.93%
ROICexgc 82.32%
OM 10.43%
PM (TTM) 2.08%
GM 46.49%
FCFM 15.84%
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score6
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.38
Debt/EBITDA 0.26
Cap/Depr 51.55%
Cap/Sales 6.5%
Interest Coverage 118.08
Cash Conversion 96.95%
Profit Quality 760.91%
Current Ratio 1.26
Quick Ratio 1.15
Altman-Z 20.8
F-Score6
WACC9.51%
ROIC/WACC1.47
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y143.35%
EPS Next 2Y60.03%
EPS Next 3Y43.73%
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3Y8.34%
Revenue Next 5YN/A
EBIT growth 1Y128.34%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year218.16%
EBIT Next 3Y57.55%
EBIT Next 5YN/A
FCF growth 1Y212.1%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y43.66%
OCF growth 3Y15.69%
OCF growth 5Y22.06%

CARECLOUD INC - CCLD 8 3/4 PERP / CCLDO FAQ

What is the ChartMill fundamental rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCLDO.


What is the valuation status of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

ChartMill assigns a valuation rating of 3 / 10 to CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO). This can be considered as Overvalued.


How profitable is CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) has a profitability rating of 6 / 10.


What is the expected EPS growth for CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) stock?

The Earnings per Share (EPS) of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) is expected to grow by 143.35% in the next year.